How should low testosterone (hypogonadism) be diagnosed and managed in a male patient?

Diagnosis and Management of Low Testosterone (Hypogonadism)

Low testosterone alone is NOT hypogonadism—the diagnosis requires BOTH consistently low testosterone levels (<300 ng/dL on two separate early morning measurements) AND the presence of clinical symptoms or signs. 1

Diagnostic Criteria

Required Components for Diagnosis

The diagnosis of hypogonadism demands a two-pronged approach:

1. Biochemical Confirmation:

• Total testosterone <300 ng/dL measured on two separate occasions 1
• Both measurements must be obtained in early morning (fasting) 1
• Use the same laboratory and methodology for consistency 1
• Critical pitfall: A single low testosterone reading is insufficient—transient illness, medications (opioids, glucocorticoids), obesity, and acute stress can temporarily suppress testosterone 2, 3

2. Clinical Symptoms/Signs Must Be Present:

Key symptoms to document:

• Sexual: reduced libido, erectile dysfunction, infertility 1
• Physical: reduced energy/endurance, diminished work performance, fatigue, reduced muscle bulk 1, 4
• Cognitive: poor concentration, impaired memory, depression, reduced motivation 1
• Physical exam findings: gynecomastia, reduced body hair in androgen-dependent areas, small/soft testes, increased body fat 1

Important caveat: Validated questionnaires (like ADAM) should NOT be used to diagnose hypogonadism or replace laboratory testing 1

Diagnostic Algorithm

Step 1: Initial Assessment

Measure total testosterone if the patient has symptoms AND/OR belongs to high-risk groups:

• Unexplained anemia
• Bone density loss/fractures
• Type 2 diabetes
• HIV/AIDS
• Chronic narcotic use
• Male infertility
• Pituitary dysfunction
• Chronic corticosteroid use
• History of chemotherapy or testicular radiation 1

Step 2: Confirm Low Testosterone

If first morning total testosterone <300 ng/dL, repeat measurement on a separate morning 1

When to measure free or bioavailable testosterone:

• Obesity (decreases SHBG)
• Diabetes mellitus
• Aging (increases SHBG)
• Liver disease (increases SHBG)
• Thyroid disorders
• Total testosterone in borderline range (200-400 ng/dL) 2, 3

Step 3: Distinguish Primary vs. Secondary Hypogonadism

Measure LH and FSH levels 1, 2, 1, 2

• Primary hypogonadism: Low testosterone + elevated LH/FSH (testicular failure)
• Secondary hypogonadism: Low testosterone + low or inappropriately normal LH/FSH (hypothalamic-pituitary dysfunction)

Step 4: Additional Workup for Secondary Hypogonadism

If LH/FSH are low or inappropriately normal:

• Measure prolactin (mandatory) 1
• If prolactin elevated: evaluate for pituitary adenoma, medications causing hyperprolactinemia 1, 2
• Consider: iron studies (hemochromatosis), other pituitary hormones, MRI of pituitary if indicated 2
• Screen for: obstructive sleep apnea, genetic disorders (Kallmann syndrome), infiltrative diseases 2

Management Approach

Before Initiating Testosterone Therapy

Address reversible causes first (functional hypogonadism):

• Weight loss in obese men (obesity suppresses testosterone) 3, 5
• Discontinue or modify offending medications: opioids, glucocorticoids, anabolic steroids 2, 3
• Treat underlying conditions: poorly controlled diabetes, sleep apnea 3, 5
• Ensure patient is not acutely ill (defer diagnosis during acute illness) 2, 4

This distinction is critical: Functional hypogonadism may be reversible without testosterone therapy, whereas organic hypogonadism requires hormone replacement 3, 5

Testosterone Replacement Therapy Indications

Initiate testosterone therapy when:

• Confirmed low testosterone (<300 ng/dL on two occasions)
• Persistent symptoms despite addressing reversible causes
• No absolute contraindications present

Absolute contraindications:

• Untreated prostate cancer
• Untreated breast cancer
• Severe heart failure
• Hematocrit >48-50% 5, 6

Pre-treatment screening (men >40 years):

• Prostate-specific antigen (PSA)
• Digital rectal examination
• Hematocrit 5, 6

Monitoring on Testosterone Therapy

The evidence emphasizes that nearly half of men on testosterone therapy do not have their levels checked after starting treatment—this is unacceptable practice 1

Required monitoring:

• Testosterone levels to ensure therapeutic range is achieved
• Hematocrit (risk of polycythemia)
• PSA and prostate examination
• Symptom improvement assessment 1

Special Considerations

For men desiring fertility:

• Testosterone therapy suppresses spermatogenesis
• In secondary hypogonadism: use gonadotropin therapy instead to preserve/restore fertility 1, 5
• Selective estrogen receptor modulators may be considered in secondary hypogonadism when fertility preservation is desired 1

Key Clinical Pitfalls to Avoid

1. Do not diagnose hypogonadism based on a single testosterone measurement 1
2. Do not diagnose hypogonadism without clinical symptoms—asymptomatic men with low testosterone do not require treatment 1
3. Do not measure testosterone during acute illness 2, 4
4. Do not use afternoon/evening testosterone measurements—circadian variation makes these unreliable 1
5. Do not prescribe testosterone without first addressing obesity, medications, and comorbidities 3, 5
6. Do not start testosterone therapy without baseline PSA and hematocrit in men >40 years 5, 6
7. Do not fail to monitor patients after initiating therapy—up to 25% of men receiving testosterone do not meet diagnostic criteria, and half are never monitored 1

Evidence Quality Note

The 2018 AUA guidelines provide the most comprehensive and recent guidance on this topic 1, with strong recommendations (Grade A evidence) for the requirement of two morning measurements and the necessity of both biochemical and clinical criteria for diagnosis. The Endocrine Society guidelines 2, 3 align with these recommendations and provide additional detail on distinguishing primary from secondary hypogonadism and managing functional causes.